novo nordisk glp 1 drugs GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings EMA will monitor suicide risk

[DOI] [PMC free article] [PubMed] [Google Scholar] 799.Nagell C.F., Wettergren A., Orskov C., Holst J.J

Multifaceted roles of GLP-1 and its analogs: a review on molecular mechanisms with a cardiotherapeutic perspective

a systematic review and meta-analysis

Persistent tiredness beyond this period warrants medical evaluation for nutritional deficiencies or underlying conditions

But theyre also a reminder of what sustained investment in basic science can achieve. As UAB researchers continue to study how these drugs work and what comes next, their findings are helping move the conversation beyond hype, while working toward a clearer understanding of one of the most significant medical breakthroughs of the past decade.